Can DOTS control multidrug-resistant tuberculosis?
- 1 April 2005
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 365 (9466) , 1206-1209
- https://doi.org/10.1016/s0140-6736(05)74788-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitnessNature Medicine, 2004
- Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistanceNature Medicine, 2004
- Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, PeruNew England Journal of Medicine, 2003
- Increasing transparency in partnerships for health – introducing the Green Light CommitteeTropical Medicine & International Health, 2002
- Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant TuberculosisScience, 2002
- The Treatment of Multidrug-Resistant Tuberculosis in TurkeyNew England Journal of Medicine, 2001
- Global Trends in Resistance to Antituberculosis DrugsNew England Journal of Medicine, 2001
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000
- Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern MexicoArchives of internal medicine (1960), 2000
- Tuberculosis epidemiology and control in Veracruz, MexicoInternational Journal of Epidemiology, 1999